Thrombolytics for cardiac arrest: Case report and systematic review of controlled trials

Annals of Pharmacotherapy

Volumn 44, Issue 12, 2010, Pages 2007-2013

  Perrott, Jerrold ^a   Henneberry, Ryan J ^b,c   Zed, Peter J ^d,e  

^a ROYAL COLUMBIAN HOSPITAL   (Canada)

^b Capital Health ^*  (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cardiac arrest; Fibrinolytics; Pulmonary embolism; Thrombolysis

Indexed keywords

ADRENALIN; ATROPINE; HEPARIN; PLACEBO; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; ARTICLE; BLEEDING; BLOOD PRESSURE; CASE REPORT; CIRCULATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FIBRINOLYTIC THERAPY; HEART ARREST; HUMAN; INTENSIVE CARE; LUNG EMBOLISM; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SUBARACHNOID HEMORRHAGE; SURVIVAL; SYSTEMATIC REVIEW;

CONTROLLED CLINICAL TRIALS AS TOPIC; FIBRINOLYTIC AGENTS; HEART ARREST; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 78649980422     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P364     Document Type: Article

References (30)

1. Bailen MR, Cuadra JAR, de Hoyos EA. Thrombolysis during cardiopulmonary resuscitation in fulminant pulmonary embolism: a review. Crit Care Med 2001;29:2011-9.
2. Zahorec R. Rescue systemic thrombolysis during cardiopulmonary resuscitation. Bratisl Lek Listy 2002;103:266-9.
3. Adams BD, Kim JY, Jackson WO. Tenecteplase and return of spontaneous circulation after refractory cardiopulmonary arrest. South Med J 2004;97:1015-7.
4. Bauer MP, Vliegen HW, Huisman MV. Massive pulmonary embolism with cardiac arrest after intracardiac electrophysiological study: a strong case for venous thromboprophylaxis. Blood Coagul Fibrinolysis 2006; 17:57-8.
5. Hefer DVF, Munir A, Khouli H. Low-dose tenecteplase during cardiopulmonary resuscitation due to massive pulmonary embolism: a case report and review of previously reported cases. Blood Coagul Fibrinolysis 2007:18:691-4.
6. Flores J, de Tena JG, de Pablo R, Daguerre M. Successful outcome of cardiopulmonary arrest with systemic thrombolysis. Eur J Intern Med 2008;19:e38-9. DOI 10.1016/j.ejim.2008.01.015
7. Lapostolle F, Levasseur J, Dardel N, et al. Cardiac arrest after air travel successfully treated by presumptive fibrinolysis. Resuscitation 2009;80:606. DOI 10.1016/j.resusciation.2009.02.010
8. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 7.2: Management of cardiac arrest. Circulation 2005;112(suppl I):IV58-66. DOI 10.1161/circulationaha. 166557
9. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 7.4: Monitoring and medications. Circulation 2005;112(suppl I):IV78-83. DOI 10.1161/circulationaha. 166559
10. Kurkciyan I, Meron G, Sterz F, et al. Pulmonary embolism as cause of cardiac arrest: presentation and outcome. Arch Intern Med 2000;160: 1529-35. (Pubitemid 30327459)
11. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines. 8th ed. Chest 2008;133:454S-545S. DOI 10.1378/chest.08-0658
12. Dong BR, Hao Q, Yue J, Wu T, Liu GJ. Thrombolytic therapy for pulmonary embolism. Cochrane Database of Systematic Reviews 2009;3: CD004437. DOI 10.1002/14651858.CD004437.pub3
13. Worster A, Smith C, Silver S, Brown MD. Thrombolytic therapy for sub-massive pulmonary embolism? Ann Emerg Med 2007;50:78-84. DOI 10.1016/j.annemergmed.2007.01.002
14. Konstantinides S, Geibel A, Heusel G, Heinrich R, Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002;347:1143-50.
15. Jerjes-Sanches C, Ramirez-Rivera A, de Lourdes Garcia M, et al. Strep-tokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis 1995;2: 227-9. DOI 10.1007/bf01062714
16. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993;341:507-11.
17. Courtney DM, Sasser HC, Pincus CL, Kline JA. Pulseless electrical activity with witnessed arrest as a predictor of sudden death from massive pulmonary embolism in outpatients. Resuscitation 2001;49:265-72.
18. Stueven HA, Aufderheide T, Waite EM, Mateer JR. Electromechanical dissociation: six years prehospital experience. Resuscitation 1989;17: 173-82. (Pubitemid 19137802)
19. Bonnin MJ, Pepe PE, Kimball KT, Clark PS. Distinct criteria for termination of resuscitation in the out-of-hospital setting. JAMA 1993;270: 1457-62.
20. Cripps T, Camm J. The management of electromechanical dissociation. Resuscitation 1991;22:173-80.
21. Langdon RW, Swicegood WR, Schwartz DA. Thrombolytic therapy of massive pulmonary embolism during prolonged cardiac arrest using recombinant tissue-type plasminogen activator. Ann Emerg Med 1989;18: 678-80.
22. Tiffany PA, Schultz M, Steuven H. Bolus thrombolytic infusions during CPR for patients with refractory arrest rhythms: outcome of a case series. Ann Emerg Med 1998;31:124-6. DOI 10.1016/s0196.0644(98)70295-1
23. Newman DH, Greenwald I, Callaway CW. Cardiac arrest and the role of thrombolytic agents. Ann Emerg Med 2000;35:472-80. DOI 10.1067/mem.2000.105600
24. Lederer W, Lichtenberger C, Pechlaner C, Kroesen G, Baubin M. Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation 2001;50:71-6. DOI 10.1016/S0300-9572(01)00317-3 (Pubitemid 32727301)
25. Clark K, Abu-Laban RB, Zed PJ, Graham L. Neurologically normal survival after fibrinolysis during prolonged cardiac arrest: case report and discussion. Can J Emerg Med 2003;5:49-53.
26. Bottiger BW, Bode C, Kern S, et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet 2001;357:1583-5. DOI 10.1016/s0140-6736(00) 04726-7
27. Abu-Laban RB, Christenson JM, Innes GD, et al. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med 2002;346:1522-8.
28. Fatovich DM, Dobb GJ, Clugston RA. A pilot trial of thrombolysis in cardiac arrest (the TICA trial). Resuscitation 2004;61:309-13. DOI 10.1016/j.resuscitation.2004.01.016
29. Bozeman WP, Kleiner DM, Ferguson KL. Empiric tenecteplase is associated with increased return of spontaneous circulation and short term survival in cardiac arrest patients unresponsive to standard interventions. Resuscitation 2006;69:399-406. DOI 10.1016/j.resuscitation.2005.09.027
30. Bottiger BW, Arntz HR, Chamberlain DA, et al. Thrombolysis during resuscitation for out-of-hospital cardiac arrest. N Engl J Med 2008;359: 2651-62.